Literature DB >> 27015862

The roles of 18F-FDG-PET/CT and US-guided FNAC in assessment of axillary nodal metastases in breast cancer patients.

Yasuharu Nakano1, Masakuni Noguchi2, Miki Yokoi-Noguchi1, Yukako Ohno1, Emi Morioka1, Takeo Kosaka3, Tomoko Takahashi4, Hiroshi Minato5.   

Abstract

BACKGROUND: There is a need for less invasive techniques for preoperative identification of axillary lymph node (ALN) metastases.
METHOD: Patients underwent ultrasonography (US) and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT), and then US-guided fine needle aspiration cytology (FNAC) and/or sentinel lymph node (SLN) biopsy were performed based on the US findings of the ALNs. Subsequently, patients with positive FNAC as well as those with positive SLN underwent axillary lymph node dissection (ALND). Postoperatively, removed SLNs and ALNs were examined histologically.
RESULTS: Fifty (85 %) of 59 patients with positive 18F-FDG uptake in the axilla had axillary metastases, but 18F-FDG uptake results were false-positive in 9 (15 %) cases. On the other hand, 29 patients with positive FNAC underwent ALND without the need for SLN biopsy, while the remaining 20 patients with negative FNAC as well as 249 patients with negative US findings underwent SLN biopsy. Subsequently, 68 patients with positive SLN underwent ALND.
CONCLUSIONS: Positive FDG uptake in the axilla does not always indicate axillary metastasis. US-guided FNAC is useful to avoid unnecessary ALND in patients with positive 18F-FDG uptake. However, SLN biopsy is needed in patients with negative US findings of the ALNs and those with negative FNAC.

Entities:  

Keywords:  Axillary lymph node metastasis; Breast cancer; Fine needle aspiration cytology; Positron emission tomography

Mesh:

Substances:

Year:  2016        PMID: 27015862     DOI: 10.1007/s12282-016-0684-5

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  4 in total

1.  A clinical compilation of lymph node pathologies comparing the diagnostic performance of biopsy methods.

Authors:  Deniz Özel; Tamer Aydın
Journal:  J Ultrasound       Date:  2018-10-04

2.  Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.

Authors:  Almir Bitencourt; Carolina Rossi Saccarelli; Elizabeth A Morris; Jessica Flynn; Zhigang Zhang; Atif Khan; Erin Gillespie; Oren Cahlon; Boris Mueller; John J Cuaron; Beryl McCormick; Simon N Powell; George Plitas; Pedram Razavi; Katja Pinker; Christopher C Riedl; Elizabeth J Sutton; Lior Z Braunstein
Journal:  JAMA Netw Open       Date:  2020-10-01

3.  Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients.

Authors:  Hazem I Assi; Ibrahim A Alameh; Jessica Khoury; Maroun Bou Zerdan; Vanessa Akiki; Maya Charafeddine; Ghida I El Saheb; Fares Sukhon; Eman Sbaity; Serine Baydoun; Nina Shabb; Ghina Berjawi; Mohamad B Haidar
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

Review 4.  Can We Identify or Exclude Extensive Axillary Nodal Involvement in Breast Cancer Patients Preoperatively?

Authors:  Martijn Leenders; Gaëlle Kramer; Kamar Belghazi; Katya Duvivier; Petrousjka van den Tol; Hermien Schreurs
Journal:  J Oncol       Date:  2019-11-22       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.